“In situ” and “invasive” are the two most important describing words in breast cancer, and they answer one question: have the changed cells stayed inside the tiny structure where they started — a milk duct or a lobule — or have they grown through its wall into the tissue around it? In situ means the cells are still in their original place. Invasive means they have crossed that boundary. Almost every other word in a diagnosis builds on this one distinction.
Key Takeaways
- In situ is Latin for “in its original place”: the cells are contained inside a duct or lobule and cannot spread elsewhere as they are.
- Invasive (also called infiltrating) means cells have grown through the wall of the duct or lobule into nearby breast tissue.
- Invasive is not the same as metastatic. Metastatic means cancer has been found in distant parts of the body; most invasive breast cancer has not done that.
- In situ findings are stage 0. Invasive cancers are staged 1–3 by size and lymph nodes, or stage 4 if distant spread is found.
- Both findings are taken seriously, and both are described further by grade and receptor tests. Your own report is individual, and your care team can explain how the words apply to you.
A Simple Picture to Hold On To
Imagine a garden bed edged with a low border. In an in situ finding, the plants are growing inside the bed — crowded, perhaps, and not the plants you would choose, but inside the border. In an invasive cancer, roots and shoots have crossed the border into the lawn beyond. The plants have not reached the far end of the garden; they have simply left the bed.
The analogy is imperfect, but the structure is right: a boundary exists, and the key question is whether it has been crossed. In the breast, the boundary is the wall of a milk duct or a lobule. Our pillar guide to types of breast cancer compared shows how this split organizes the whole family of types.
“In Situ,” Word by Word
The phrase comes from Latin and means “in its original place.” A pathologist — a doctor who identifies diseases by examining tissue — uses it when changed cells are found inside a duct or lobule with the wall of that structure intact.
The two in situ findings you are most likely to meet are DCIS, in a duct, and LCIS, in a lobule. They share the “in situ” label but are understood differently: DCIS is treated as stage 0 cancer, while LCIS is usually described as a marker of higher future risk rather than a cancer itself. Our comparison of DCIS vs LCIS explains that difference in full. What they have in common is the boundary: because the cells are contained, they have no route to lymph nodes or distant parts of the body.
“Invasive,” Word by Word
“Invasive” means the cells have grown through the wall of the duct or lobule into the breast tissue around it. Reports sometimes use the older word “infiltrating” for the same idea — invasive ductal carcinoma and infiltrating ductal carcinoma are the same diagnosis.
Once cells are in open tissue, they are near lymph channels and blood vessels, so spread becomes possible in principle. That is why an invasive diagnosis sets a wider process in motion: measuring the cancer, checking lymph nodes, and testing the cells for receptors. It does not mean spread has happened — only that the question now has to be asked and answered. The pair at the heart of this article is compared directly in our guide to DCIS vs invasive ductal carcinoma.
Invasive Is Not the Same as Metastatic
This is the most common point of confusion, and clearing it up matters. “Invasive” describes growth into nearby tissue. “Metastatic” describes cancer found in distant parts of the body — bones, liver, lungs, or brain, for example. An invasive cancer may be small, confined to the breast, and nowhere else; that is, in fact, how many are found. Metastatic breast cancer is a separate, specific finding, and it is staged differently. If your report says “invasive” and does not mention distant sites, those are two different statements, and your team can confirm what has and has not been found.
The Two Terms, Side by Side
| In Situ | Invasive | |
|---|---|---|
| Where the cells are | Inside a duct or lobule; the wall is intact | Through the wall, into nearby breast tissue |
| Examples | DCIS (in a duct); LCIS (in a lobule) | Invasive ductal carcinoma; invasive lobular carcinoma |
| Could it reach lymph nodes as it is? | No | It has the potential to, so nodes are usually checked |
| Stage connection | Stage 0 | Stage 1–3 by size and nodes; stage 4 only if distant spread is found |
| Other words for it | Non-invasive; pre-invasive (sometimes used for DCIS) | Infiltrating |
| General direction of next steps | Focused on the area and on future risk | Wider: breast, lymph nodes, receptor results, whole-body considerations |
How These Words Appear on a Pathology Report
A diagnosis line combines several answers at once. It may begin with the in situ or invasive statement — “ductal carcinoma in situ” or “invasive ductal carcinoma” — then add the grade of the cells and the receptor results. A single specimen can also contain both patterns: an invasive cancer with an area of DCIS beside it is a common report, and in that case planning is based on the invasive part.
One more word you may see is “microinvasion”: extremely small spots where cells have just begun to grow beyond the duct within an area of DCIS. It is the borderline case between the two categories. If any wording on your report is unfamiliar, our guide to understanding your breast cancer pathology report translates the common terms into plain language.
Why the Distinction Guides Next Steps
Because an in situ finding cannot spread as it is, discussions focus on the local area and on reducing future risk. Because an invasive cancer can potentially spread, discussions add lymph node checks and receptor-driven decisions about medicines that work throughout the body. Grade and receptor results then refine both pictures. None of this is a recommendation — plans are built from the full report, your health, and your preferences, in conversation with your care team. General background from the National Cancer Institute and the American Cancer Society can help you prepare for that conversation.
Questions to Ask Your Doctor
- Is my finding in situ, invasive, or a mixture of both?
- Which structure did it start in — a duct or a lobule?
- Does my report mention microinvasion, and if so, what does it change?
- What stage does this correspond to, and what information is still being gathered?
- Have my lymph nodes been checked, or will they be?
- What are my grade and receptor results, in plain language?
- Can you read my diagnosis line aloud and explain each part?
Frequently Asked Questions
Is in situ cancer really cancer?
For DCIS, yes — it is classified as stage 0 breast cancer: the cells look like cancer but have not invaded nearby tissue. LCIS carries the same “in situ” wording but is usually described as a risk marker rather than a cancer. In both cases, the essential point is containment: neither can spread while it remains in situ.
Can an in situ finding become invasive?
Some DCIS may develop into invasive cancer in the same area over time, and some may not; there is currently no test that can sort one from the other in advance, which is why treatment and follow-up are discussed. LCIS works differently — it signals a raised chance of cancer developing later in either breast rather than transforming in place.
Does “invasive” mean the cancer is fast-growing?
No. Invasive describes location — growth beyond the original structure — not speed. How different the cells look and how quickly they appear to be dividing is captured by the grade, a separate part of the report. An invasive cancer can be slow-growing, and grade is one of the details your team uses when planning.
Does invasive mean it has spread through my body?
No. Invasive means growth into nearby breast tissue. Spread to distant parts of the body is called metastatic disease, which is a separate finding that requires its own evidence. Many invasive cancers are found while they are only in the breast and nearby lymph nodes.
What is the difference between invasive and infiltrating?
Nothing — the words are used interchangeably. Older reports favor “infiltrating ductal carcinoma,” newer ones usually say “invasive ductal carcinoma.” Both mean cancer that started in a duct and grew beyond it.
What stage is an in situ finding?
Stage 0. Invasive cancers are staged from 1 upward depending on size and lymph node involvement. Our overview of breast cancer stages 0 to 4 explains how the staging system fits together.
Related Articles
- Types of Breast Cancer Compared — the complete guide to how the types are classified and how they differ.
- DCIS vs Invasive Ductal Carcinoma — what changes when ductal cancer crosses the duct wall.
- DCIS vs LCIS — how the two in situ findings differ from each other.
- Breast Cancer Stages 0 to 4 Explained — how stage builds on the in situ and invasive labels.
- Understanding Your Breast Cancer Pathology Report — the common report words, translated into plain English.
This article is for general educational purposes only and is not medical, legal, or financial advice. It does not replace professional care. Talk to your doctor or care team about your own situation. If you think you may have a medical emergency, call 911.